Search

Author/Creator Thellenberg-Karlsson, Camilla

1. A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases. (March 2023)

Authors:
Thellenberg-Karlsson, Camilla; Vjaters, Egils; Kase, Marju; Tammela, Teuvo; Ojamaa, Kristiina; Norming, Ulf; Nyman, Claes; Andersson, Sven-Olof; Hublarovs, Oleg; Marquez-Holmberg, Marcela; Castellanos, Enrique; Ullen, Anders; Holmberg, Anders; Nilsson, Sten
Journal:
European journal of cancer
Issue:
Volume 181(2023)
Page Start:
198
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy. (January 2021)

Authors:
Björeland, Ulrika; Nyholm, Tufve; Jonsson, Joakim; Skorpil, Mikael; Blomqvist, Lennart; Strandberg, Sara; Riklund, Katrine; Beckman, Lars; Thellenberg-Karlsson, Camilla
Journal:
Physics and imaging in radiation oncology
Issue:
Volume 17(2021)
Page Start:
117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial. Issue 2 (February 2021)

Authors:
Fransson, Per; Nilsson, Per; Gunnlaugsson, Adalsteinn; Beckman, Lars; Tavelin, Björn; Norman, David; Thellenberg-Karlsson, Camilla; Hoyer, Morten; Lagerlund, Magnus; Kindblom, Jon; Ginman, Claes; Johansson, Bengt; Björnlinger, Kirsten; Seke, Mihajl; Agrup, Måns; Zackrisson, Björn; Kjellén, Elisab...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 2(2021)
Page Start:
235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗